Reputation, Responsibility, and the Long Game in Biotech | Edwin Moses × The End (Ep. 3) скачать в хорошем качестве

Reputation, Responsibility, and the Long Game in Biotech | Edwin Moses × The End (Ep. 3)

For this episode of The End Podcast, Biorce CEO Pedro Coelho sits down with Edwin Moses, former CEO of Ablynx, who led the company for over 12 years — scaling it from a small R&D-focused team into a 500-person biotech before its $4.8B acquisition by Sanofi. They talk about what responsible scaling really demands when science, capital, and patients are all on the line. They discuss: • What are the capabilities a biotech need in order to scale • How to make long-term decisions under investor pressure • What leadership looks like during and after an exit • Why responsibility compounds with experience In biotech, scale without discipline doesn’t last. That’s the standard we believe in. ___________________________________________________________________ Biorce is a healthtech company focused on accelerating clinical trials, making them faster and more efficient. Aika is Biorce’s AI-powered platform, the first AI-native solution designed to accelerate clinical trial setup and reduce risk by integrating protocol design, feasibility and regulatory planning. #TheEndPodcast #ClinicalTrials #Pharma #AI #DrugDevelopment #Biotech #HealthTech #Biorce